{"title":"[Long COVID - neurological or somatoform disease?]","authors":"Dalma Tényi, Tamás Tényi, József Janszky","doi":"10.18071/isz.77.0397","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>Post-COVID condition (also known as long COVID) is a syndrome characterized by persistent symptoms following a suspected or confirmed SARS-CoV-2 infection, lasting for at least two months and are not attributable to other conditions. The most common symptoms include fatigue, diffuse pain, post-exertional malaise and “brain fog” (impairment of memory and concentration). The pathomechanism of long COVID is the subject of ongoing, intensive research. Our purpose was to review the literature on the pathomechanism of long COVID.</p><p><strong>Methods: </strong>We reviewed original and review articles in Hungarian and English on the pathomechanism of long COVID, published between January 2019 and June 2024, in the PubMed and Google Scholar databases.</p><p><strong>Results: </strong>Potential underlying causes of the symptoms are outlined in three main theories. 1) The concept of “long COVID as a distinct neurological disease” suggests that direct viral neuroinvasion, apoptosis, and demyelination processes are responsible for the symptoms. 2) The theory of “long COVID as a systemic disease with neurological symptoms” is based on the virus induced, prolonged cytokine and chemokine release, as well as the reactivation of latent viral infections. 3) According to the concept of “long COVID as a somatoform disorder”, the disease results from abnormal activation of the proinflammatory cytokine network leading to central nervous system sensitization, a well-known psychoneuroimmunological mechanism. Our study highlighted significant overlaps between long COVID and conditions such as chronic fatigue syndrome/myalgic encephalomyelitis, a group of symptoms not defined as a distinct mental disorder in DSM-5, but commonly referred to as Gulf War syndrome, chronic Lyme disease and somatic symptom disorder.</p><p><strong>Conclusion: </strong>The pathomechanism of long COVID, which presents with a wide range of nonspecific symptoms, remains unknown, and no reproducible disease-specific biomarker has been identified to date. Clarifying the etiology of the disease is crucial for determining adequate and effective therapeutic methods.</p>","PeriodicalId":50394,"journal":{"name":"Ideggyogyaszati Szemle-Clinical Neuroscience","volume":"77 11-12","pages":"397-405"},"PeriodicalIF":0.9000,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ideggyogyaszati Szemle-Clinical Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18071/isz.77.0397","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and purpose: Post-COVID condition (also known as long COVID) is a syndrome characterized by persistent symptoms following a suspected or confirmed SARS-CoV-2 infection, lasting for at least two months and are not attributable to other conditions. The most common symptoms include fatigue, diffuse pain, post-exertional malaise and “brain fog” (impairment of memory and concentration). The pathomechanism of long COVID is the subject of ongoing, intensive research. Our purpose was to review the literature on the pathomechanism of long COVID.
Methods: We reviewed original and review articles in Hungarian and English on the pathomechanism of long COVID, published between January 2019 and June 2024, in the PubMed and Google Scholar databases.
Results: Potential underlying causes of the symptoms are outlined in three main theories. 1) The concept of “long COVID as a distinct neurological disease” suggests that direct viral neuroinvasion, apoptosis, and demyelination processes are responsible for the symptoms. 2) The theory of “long COVID as a systemic disease with neurological symptoms” is based on the virus induced, prolonged cytokine and chemokine release, as well as the reactivation of latent viral infections. 3) According to the concept of “long COVID as a somatoform disorder”, the disease results from abnormal activation of the proinflammatory cytokine network leading to central nervous system sensitization, a well-known psychoneuroimmunological mechanism. Our study highlighted significant overlaps between long COVID and conditions such as chronic fatigue syndrome/myalgic encephalomyelitis, a group of symptoms not defined as a distinct mental disorder in DSM-5, but commonly referred to as Gulf War syndrome, chronic Lyme disease and somatic symptom disorder.
Conclusion: The pathomechanism of long COVID, which presents with a wide range of nonspecific symptoms, remains unknown, and no reproducible disease-specific biomarker has been identified to date. Clarifying the etiology of the disease is crucial for determining adequate and effective therapeutic methods.
背景和目的:COVID后症状(也称为长COVID)是一种综合征,其特征是疑似或确诊SARS-CoV-2感染后持续出现症状,持续至少两个月,且不能归因于其他疾病。最常见的症状包括疲劳、弥漫性疼痛、运动后不适和脑雾。(记忆力和注意力的损害)。长冠状病毒病的发病机制是目前深入研究的课题。方法:我们回顾了2019年1月至2024年6月在PubMed和谷歌Scholar数据库中发表的关于长冠肺炎病理机制的匈牙利语和英语的原文和综述文章。结果:症状的潜在潜在原因主要有三种理论。1) long COVID作为一种独特的神经系统疾病的概念;提示直接的病毒神经侵入、细胞凋亡和脱髓鞘过程是导致这些症状的原因。2)将COVID视为具有神经系统症状的全身性疾病的理论;是基于病毒诱导,延长细胞因子和趋化因子的释放,以及潜伏病毒感染的再激活。3)根据“COVID - 19是一种躯体形式疾病”的概念,该疾病是由于促炎细胞因子网络异常激活导致中枢神经系统致敏,这是一种众所周知的心理神经免疫机制。我们的研究强调了长期COVID与慢性疲劳综合征/肌痛性脑脊髓炎等疾病之间的显著重叠,这组症状在DSM-5中未被定义为独特的精神障碍,但通常被称为海湾战争综合征、慢性莱姆病和躯体症状障碍。长冠状病毒病表现出广泛的非特异性症状,其发病机制尚不清楚,迄今尚未发现可重复的疾病特异性生物标志物。弄清该病的病因对于确定适当和有效的治疗方法至关重要。
期刊介绍:
The aim of Clinical Neuroscience (Ideggyógyászati Szemle) is to provide a forum for the exchange of clinical and scientific information for a multidisciplinary community. The Clinical Neuroscience will be of primary interest to neurologists, neurosurgeons, psychiatrist and clinical specialized psycholigists, neuroradiologists and clinical neurophysiologists, but original works in basic or computer science, epidemiology, pharmacology, etc., relating to the clinical practice with involvement of the central nervous system are also welcome.